Rishi Venkata Puram, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antigens, Human Platelet | 1 | 2020 | 41 | 0.690 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2020 | 577 | 0.570 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2020 | 245 | 0.510 |
Why?
|
| CLOCK Proteins | 1 | 2016 | 87 | 0.510 |
Why?
|
| ARNTL Transcription Factors | 1 | 2016 | 97 | 0.500 |
Why?
|
| Autoantibodies | 1 | 2020 | 2114 | 0.370 |
Why?
|
| Neoplastic Stem Cells | 2 | 2016 | 1349 | 0.360 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2020 | 2764 | 0.300 |
Why?
|
| Leukemia, Myeloid, Acute | 4 | 2016 | 3626 | 0.290 |
Why?
|
| Thrombosis | 1 | 2020 | 2954 | 0.260 |
Why?
|
| Pipecolic Acids | 1 | 2020 | 77 | 0.170 |
Why?
|
| Drug Substitution | 1 | 2020 | 292 | 0.140 |
Why?
|
| Coronary Thrombosis | 1 | 2020 | 440 | 0.140 |
Why?
|
| Platelet Transfusion | 1 | 2020 | 301 | 0.140 |
Why?
|
| Arginine | 1 | 2020 | 931 | 0.130 |
Why?
|
| RNA Interference | 2 | 2016 | 2829 | 0.130 |
Why?
|
| Thrombectomy | 1 | 2020 | 676 | 0.120 |
Why?
|
| Shock, Cardiogenic | 1 | 2020 | 709 | 0.120 |
Why?
|
| Casein Kinase Ialpha | 1 | 2014 | 26 | 0.110 |
Why?
|
| Bone Marrow Neoplasms | 1 | 2014 | 101 | 0.110 |
Why?
|
| Gene Knockout Techniques | 1 | 2016 | 804 | 0.100 |
Why?
|
| Integrin beta3 | 1 | 2013 | 120 | 0.100 |
Why?
|
| RNA, Small Interfering | 3 | 2016 | 3427 | 0.100 |
Why?
|
| Warfarin | 1 | 2020 | 1493 | 0.090 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2016 | 754 | 0.090 |
Why?
|
| Thrombolytic Therapy | 1 | 2020 | 2054 | 0.090 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2013 | 719 | 0.090 |
Why?
|
| Sulfonamides | 1 | 2020 | 1982 | 0.090 |
Why?
|
| SOXD Transcription Factors | 1 | 2010 | 44 | 0.090 |
Why?
|
| Drug Therapy, Combination | 1 | 2020 | 6310 | 0.090 |
Why?
|
| gamma-Globins | 1 | 2010 | 105 | 0.080 |
Why?
|
| Erythroid Cells | 1 | 2010 | 237 | 0.080 |
Why?
|
| Aspirin | 1 | 2020 | 3135 | 0.080 |
Why?
|
| Stents | 1 | 2020 | 3193 | 0.080 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 8535 | 0.070 |
Why?
|
| Repressor Proteins | 2 | 2016 | 2979 | 0.070 |
Why?
|
| Gene Silencing | 2 | 2014 | 1505 | 0.070 |
Why?
|
| Homeodomain Proteins | 1 | 2016 | 2429 | 0.070 |
Why?
|
| Hematopoiesis | 1 | 2016 | 2056 | 0.070 |
Why?
|
| Leukemia | 1 | 2013 | 1518 | 0.060 |
Why?
|
| Circadian Rhythm | 1 | 2016 | 2591 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 2952 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2016 | 3792 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 8628 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2016 | 22361 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 18330 | 0.040 |
Why?
|
| Mice | 6 | 2016 | 81912 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2010 | 3610 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2010 | 4925 | 0.030 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2016 | 1608 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2010 | 5794 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 18063 | 0.030 |
Why?
|
| Animals | 6 | 2016 | 168965 | 0.030 |
Why?
|
| Ribosomal Protein S6 | 1 | 2014 | 70 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2016 | 23621 | 0.030 |
Why?
|
| Cell Line, Tumor | 3 | 2016 | 17097 | 0.030 |
Why?
|
| Lovastatin | 1 | 2013 | 114 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2013 | 3408 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 13650 | 0.020 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2013 | 308 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2016 | 3093 | 0.020 |
Why?
|
| Humans | 7 | 2020 | 767040 | 0.020 |
Why?
|
| GATA1 Transcription Factor | 1 | 2010 | 306 | 0.020 |
Why?
|
| Cell Death | 1 | 2014 | 1677 | 0.020 |
Why?
|
| Small Molecule Libraries | 1 | 2014 | 742 | 0.020 |
Why?
|
| beta Catenin | 1 | 2013 | 1048 | 0.020 |
Why?
|
| Erythropoiesis | 1 | 2010 | 691 | 0.020 |
Why?
|
| Middle Aged | 1 | 2020 | 223233 | 0.020 |
Why?
|
| Cell Movement | 1 | 2016 | 5203 | 0.010 |
Why?
|
| Protein Transport | 1 | 2010 | 1944 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 3828 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2014 | 8310 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2016 | 7611 | 0.010 |
Why?
|
| Base Sequence | 1 | 2013 | 12414 | 0.010 |
Why?
|
| Male | 1 | 2020 | 364203 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 17608 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 9532 | 0.010 |
Why?
|
| Histones | 1 | 2010 | 2597 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2016 | 11657 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2013 | 3249 | 0.010 |
Why?
|
| Protein Binding | 1 | 2010 | 9327 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2013 | 14476 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 5693 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2016 | 12790 | 0.010 |
Why?
|
| Cell Line | 1 | 2010 | 15567 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 65295 | 0.000 |
Why?
|
| Adult | 1 | 2010 | 223317 | 0.000 |
Why?
|